Abstract
1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan- 4-one has been successfully synthesized via a multi-step pathway starting from 2-nitroaniline. Structure characterization of this original pyrrolo[1,2-a]quinoxaline derivative was achieved by FT- IR,1H-NMR,13C-NMR, X-Ray and HRMS spectral analysis. This title compound shows interesting cytotoxic potential against several human leukemia cell lines (K562, HL60, and U937 cells).
Author supplied keywords
Cite
CITATION STYLE
Guillon, J., Savrimoutou, S., Rubio, S., Moreau, S., Pinaud, N., Marchivie, M., & Desplat, V. (2020). 1-phenyl-8-[[4-(Pyrrolo[1,2-a]quinoxalin-4- yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one: Synthesis, crystal structure and anti-leukemic activity. MolBank, 2020(1). https://doi.org/10.3390/M1113
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.